the invention discloses use of peptide containing an essential ventricular myosin light chain type 1 amino acid sequence , which is functional as cleavage site for caspase - 3 , in the screening for a compound for the treatment of chronic or acute cardiovascular disease . further , screening methods for inhibitors of the caspase - 3 - mediated cleavage of vmlc1 are disclosed .